Galmed PharmaceuticalsGLMD
那斯達克 · USD
1.46
+0.04
(+2.82%)
收盤 08/14 03:26 (UTC+8)
盤後
1.43
1.43
(-2.05%)
08/14 03:26 (UTC+8)
Galmed PharmaceuticalsGLMD
1.46
+0.04
(+2.82%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
營業費用 | 1,264 | 1,644 | 2,011 | 1,222 | 1,401 | 2,151 | 1,468 | 1,871 | 2,002 | 2,449 |
研發費用 | 634 | 1,072 | 738 | 534 | 635 | 1,121 | 556 | 809 | 1,083 | 1,378 |
推銷及管理費用 | 630 | 572 | 1,273 | 688 | 766 | 1,030 | 912 | 1,062 | 919 | 1,071 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -1,264 | -1,644 | -2,011 | -1,222 | -1,401 | -2,151 | -1,468 | -1,871 | -2,002 | -2,449 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -1,104 | -3,209 | -1,914 | -1,119 | -1,275 | -2,016 | -1,473 | -1,593 | -1,830 | -2,639 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -1,104 | -3,209 | -1,914 | -1,119 | -1,275 | -2,016 | -1,473 | -1,593 | -1,830 | -2,639 |
基本每股稅後盈餘(元) | -0.62 | 36.16 | -27.72 | -0.18 | -0.17 | - | -3.43 | -0.95 | -0.07 | -0.01 |
稀釋每股稅後盈餘(元) | -0.62 | 36.16 | -27.72 | -0.18 | -0.17 | - | -3.43 | -0.95 | -0.07 | -0.01 |
基本平均股數(千股) | 1779.00 | 2675.00 | 69.00 | 6294.00 | 7300.00 | - | 520.00 | 1680.00 | 25385.00 | 302450.00 |
稀釋平均股數(千股) | 1779.00 | 2675.00 | 69.00 | 6294.00 | 7300.00 | - | 520.00 | 1680.00 | 25385.00 | 302450.00 |
還原基本每股稅後盈餘(元) | -0.62 | 36.16 | -27.72 | -2.16 | -2.10 | - | -41.16 | -11.40 | -12.96 | -1.50 |
還原稀釋每股稅後盈餘(元) | -0.62 | 36.16 | -27.72 | -2.16 | -2.10 | - | -41.16 | -11.40 | -12.96 | -1.50 |
還原基本平均股數(千股) | 1,779 | 2,675 | 69 | 524 | 608 | - | 43 | 140 | 141 | 1,680 |
還原稀釋平均股數(千股) | 1,779 | 2,675 | 69 | 524 | 608 | - | 43 | 140 | 141 | 1,680 |
EBITDA(千元) | -1,104 | -3,209 | -1,914 | -1,045 | -1,266 | -2,010 | -1,465 | -1,584 | -1,822 | -2,630 |